Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
CHAD Therapeutics, Inc. (AMEX:CTU) announced today that it plans to withdraw its common stock from the American Stock Exchange effective on August 29, 2008 because the Company...
Dormio Tech, a division of CHAD Therapeutics, Inc. (AMEX:CTU), announced today that it received 510(K) clearance from the FDA to market the Company's proprietary FloCHANNEL?...
CHAD Therapeutics, Inc. (AMEX:CTU) today announced that on July 23, 2008, it received a letter from the American Stock Exchange ("AMEX") stating that the Company was not in...
CHAD Therapeutics, Inc. (AMEX:CTU) today reported that its independent registered accountants, Rose, Snyder & Jacobs, had qualified their opinion on the Company's March 31...
CHAD Therapeutics, Inc. (AMEX:CTU) announced today that it has closed the sale of the assets related to its transfilling oxygen business for $1.825 million in cash, pursuant to...
CHAD Therapeutics, Inc. (AMEX:CTU) announced that it has closed the sale of the assets related to CHAD's oxygen conserving business to Inovo, Inc., a privately held manufacturer...
CHAD Therapeutics, Inc. (AMEX:CTU) today announced operating results for the third quarter and first nine months of fiscal 2008. "As previously announced, CHAD has decided to...
Following a special meeting of shareholders held today, CHAD Therapeutics, Inc. (AMEX:CTU) announced that its shareholders have approved the proposed sale for approximately...
CHAD Therapeutics, Inc. (AMEX:CTU) announced today that it has commenced mailing its definitive proxy statement to shareholders for approval of its proposed sale of assets...
CHAD Therapeutics, Inc. (AMEX:CTU) today reported financial results for the first quarter of fiscal 2008. First Quarter Results For the three months ended June 30, 2007...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
